Back

Leucine zipper-based sorting system enables generation of multi-functional CAR T cells

James, S. E.; Chen, S.; Ng, B. D.; Fischman, J. S.; Jahn, L.; Boardman, A. P.; Rajagopalan, A.; Elias, H. K.; Massa, A.; Manuele, D.; Nichols, K. B.; Lazrak, A.; Lee, N.; Fei, T.; DeWolf, S.; Peled, J.; Vardhana, S. A.; Klebanoff, C. A.; van den Brink, M. R. M.

2023-09-13 synthetic biology
10.1101/2023.09.13.557232 bioRxiv
Show abstract

Resistance to chimeric antigen receptor (CAR) T cell therapy develops through multiple mechanisms including antigen-loss escape and tumor-induced immune suppression. Expression of multiple CARs may overcome multi-antigen-loss escape. Similarly, expression of switch receptors that convert inhibitory immune checkpoint signals into positive costimulatory signals may enhance CAR T cell activity in the tumor microenvironment. Engineering multiple features into one cell product, however, is limited by transgene packaging constraints of current vector systems. Here, we describe a leucine zipper-based cell sorting methodology that enables selective single-step immunomagnetic purification of cells co-transduced with two vectors, designed to potentially double the number of incorporated transgenes. This "Zip-sorting" system facilitated generation of T cells simultaneously expressing up to four CARs and co-expressing up to three switch receptors. These multi-CAR multi-Switch receptor arrays enabled T cells to eliminate antigenically heterogeneous syngeneic leukemia populations co-expressing multiple inhibitory ligands. Zip-sorted multi-CAR multi-Switch receptor T cells represent a potent therapeutic strategy to overcome multiple mechanisms of CAR T cell resistance.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Nature Communications
4913 papers in training set
Top 17%
10.2%
2
Bioconjugate Chemistry
17 papers in training set
Top 0.1%
10.2%
3
ACS Synthetic Biology
256 papers in training set
Top 0.5%
9.2%
4
eLife
5422 papers in training set
Top 11%
6.9%
5
Molecular Therapy
71 papers in training set
Top 0.7%
3.6%
6
Nucleic Acids Research
1128 papers in training set
Top 6%
3.6%
7
Journal for ImmunoTherapy of Cancer
64 papers in training set
Top 0.3%
3.6%
8
Nature Biotechnology
147 papers in training set
Top 3%
2.4%
9
Communications Biology
886 papers in training set
Top 4%
2.4%
50% of probability mass above
10
Circulation
66 papers in training set
Top 1%
2.1%
11
Scientific Reports
3102 papers in training set
Top 53%
1.9%
12
Leukemia
39 papers in training set
Top 0.4%
1.8%
13
PLOS ONE
4510 papers in training set
Top 53%
1.7%
14
Cell Chemical Biology
81 papers in training set
Top 2%
1.7%
15
Cell Reports Medicine
140 papers in training set
Top 4%
1.7%
16
Blood Advances
54 papers in training set
Top 0.7%
1.7%
17
Cell Reports Methods
141 papers in training set
Top 3%
1.5%
18
Nature Biomedical Engineering
42 papers in training set
Top 1.0%
1.5%
19
Journal of the American Chemical Society
199 papers in training set
Top 4%
1.2%
20
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 38%
1.2%
21
Science Advances
1098 papers in training set
Top 23%
1.2%
22
Nano Letters
63 papers in training set
Top 2%
1.2%
23
Molecular Therapy - Methods & Clinical Development
38 papers in training set
Top 0.3%
1.1%
24
Journal of Biological Chemistry
641 papers in training set
Top 3%
1.0%
25
Cancer Cell
38 papers in training set
Top 1%
1.0%
26
Nature Chemical Biology
104 papers in training set
Top 3%
0.9%
27
Advanced Science
249 papers in training set
Top 17%
0.8%
28
mAbs
28 papers in training set
Top 0.3%
0.8%
29
Science Translational Medicine
111 papers in training set
Top 6%
0.8%
30
Structure
175 papers in training set
Top 3%
0.8%